Escalon Medical Corp. (ESMC)
OTCMKTS · Delayed Price · Currency is USD
0.177074
+0.000874 (0.50%)
At close: Oct 28, 2026
Escalon Medical Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 12.74 | 12.05 | 11.98 | 12.18 | 10.7 | |
Revenue Growth | 5.73% | 0.54% | -1.63% | 13.80% | 2.21% |
Cost of Revenue | 7.17 | 6.54 | 6.84 | 6.7 | 6.1 |
Gross Profit | 5.57 | 5.51 | 5.15 | 5.48 | 4.61 |
Selling, General & Admin | 5.02 | 4.62 | 4.56 | 4.18 | 4.09 |
Research & Development | 0.5 | 0.75 | 0.69 | 0.82 | 0.99 |
Operating Expenses | 5.52 | 5.38 | 5.25 | 5 | 5.08 |
Operating Income | 0.05 | 0.13 | -0.1 | 0.48 | -0.47 |
Interest Expense | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 |
Interest & Investment Income | - | - | - | - | 0 |
Other Non Operating Income (Expenses) | 0.02 | -0.01 | - | - | - |
EBT Excluding Unusual Items | 0.06 | 0.11 | -0.13 | 0.46 | -0.49 |
Gain (Loss) on Sale of Assets | 2.81 | - | - | - | - |
Other Unusual Items | - | - | - | - | 0.51 |
Pretax Income | 2.87 | 0.11 | -0.13 | 0.46 | 0.02 |
Income Tax Expense | -1.14 | - | - | - | - |
Net Income | 4.01 | 0.11 | -0.13 | 0.46 | 0.02 |
Preferred Dividends & Other Adjustments | 2 | 0.08 | 0.05 | 0.24 | 0.05 |
Net Income to Common | 2.01 | 0.03 | -0.18 | 0.22 | -0.03 |
Net Income Growth | 7062.83% | - | - | - | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 15 | 14 | 7 | 14 | 7 |
Shares Change | 2.41% | 92.20% | -45.33% | 82.92% | - |
EPS (Basic) | 0.27 | 0.00 | -0.02 | 0.03 | -0.00 |
EPS (Diluted) | 0.27 | 0.00 | -0.02 | 0.03 | -0.00 |
EPS Growth | 7064.02% | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -0.41 | 0.38 | -0.64 | 0.32 | -1.05 |
Free Cash Flow Per Share | -0.03 | 0.03 | -0.09 | 0.02 | -0.14 |
Gross Margin | 43.73% | 45.75% | 42.95% | 45.00% | 43.04% |
Operating Margin | 0.36% | 1.11% | -0.87% | 3.93% | -4.39% |
Profit Margin | 15.80% | 0.23% | -1.48% | 1.82% | -0.31% |
Free Cash Flow Margin | -3.20% | 3.13% | -5.37% | 2.61% | -9.81% |
EBITDA | 0.07 | 0.17 | -0.06 | 0.52 | -0.42 |
EBITDA Margin | 0.53% | 1.42% | -0.49% | 4.30% | -3.94% |
D&A For EBITDA | 0.02 | 0.04 | 0.05 | 0.05 | 0.05 |
EBIT | 0.05 | 0.13 | -0.1 | 0.48 | -0.47 |
EBIT Margin | 0.36% | 1.11% | -0.87% | 3.93% | -4.39% |
Revenue as Reported | 12.74 | 12.05 | 11.98 | 12.18 | 10.7 |